Study #2024-1486
A phase 2 platform study of novel combination therapies in participants with head and neck squamous cell carcinoma. sub study title: VELOCITY-HNSCC Substudy-01: A phase 2 study of novel combination therapies in participants with previously untreated recurrent or metastatic head and neck squamous cell carcinoma regardless of PD-L1 expression status.
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Study phase:
Physician name:
Faye Johnson
Department:
Thoracic/Head & Neck Medical Oncology
For general questions about clinical trials:
1-833-992-0260
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.